Repligen
RGEN
Number of shares outstanding for Repligen (RGEN)
Number of shares outstanding as of April 2024 : 55,815,666
According to Repligen 's latest financial reports and stock price the company's current number of shares outstanding is 55,815,666. At the end of 2023 the company had 55,815,666 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Repligen from 2001 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 55.81 M | 0.49% |
| 2022 | 55.54 M | 0.43% |
| 2021 | 55.3 M | 4.07% |
| 2020 | 53.14 M | 2.07% |
| 2019 | 52.06 M | 18.65% |
| 2018 | 43.88 M | 0.72% |
| 2017 | 43.56 M | 28.77% |
| 2016 | 33.83 M | 2.69% |
| 2015 | 32.94 M | 0.61% |
| 2014 | 32.74 M | 2.6% |
| 2013 | 31.91 M | 2.52% |
| 2012 | 31.13 M | 1.09% |
| 2011 | 30.79 M | 0.03% |
| 2010 | 30.78 M | 0.09% |
| 2009 | 30.75 M | -0.17% |
| 2008 | 30.8 M | -0.47% |
| 2007 | 30.95 M | 1.9% |
| 2006 | 30.37 M | 0.9% |
| 2005 | 30.1 M | 0.13% |
| 2004 | 30.06 M | 0.62% |
| 2003 | 29.87 M | 9.38% |
| 2002 | 27.31 M | 2.53% |
| 2001 | 26.64 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 5,647,000,000 | 10,017.23% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | 387,000,000 | 593.35% | 🇺🇸 USA |
 General Electric GE | 1,091,000,000 | 1,854.65% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 2,023,000,000 | 3,524.43% | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | 177,171,000 | 217.42% | 🇺🇸 USA |
 Novavax NVAX | 103,429,000 | 85.30% | 🇺🇸 USA |
 Neurocrine Biosciences
NBIX | 97,900,000 | 75.40% | 🇺🇸 USA |
 Bio-Techne TECH | 157,533,000 | 182.24% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | 188,219,000 | 237.22% | 🇺🇸 USA |
 Charles River Laboratories
CRL | 51,283,000 | -8.12% | 🇺🇸 USA |